2025 Fall Clinical Dermatology Conference Highlights

Our Annual Fall Clinical Dermatology Conference is framed to improve our attendees' value and clinical skills through a uniquely designed educational experience. Check back here as we highlight key sessions and posters during the conference!

Looking to register for Fall Clinical 2026? Click HERE

Thursday, October 23, 2025

Check Out Highlights From FC25 Below

What’s New in the Medicine Chest – Part 1

James Q. Del Rosso, DO, opened Part 1 of his “What’s New in the Medicine Chest” series by focusing on updates in skin care, acne, rosacea, oral antibiotics,...

CME Satellite Symposium: Charting the Course to Higher Targets with JAK Inhibition in Atopic Dermatitis

Christopher Bunick, MD, PhD, and David G. Cotter, MD, PhD, delivered a comprehensive session on treatment goals and introduced the idea of a new definition for treatment success...

Psoriasis Pearls That Will Help Your Practice NOW!

Mark Lebwohl, MD, shared practical insights and clinical pearls for managing psoriasis. Dr Lebwohl highlighted that when the best treatment options underperform, clinicians should consider combination strategies, reassess...

Results of a Phase 2 Multicenter Study Evaluating the Safety and Tolerability of VP-315, an Investigational Therapy for Basal Cell Carcinoma

Authors: Neal Bhatia, MD; Jonathan Kantor, MD; Lawrence Green, MD; Jonathan Weiss, MD; Cynthia Willson, RN, BSN; Susan Cutler, DMD; Jayson Rieger, PhD, MBA; David K. Glover, ME,...

Current Topical Treatment Approaches for Managing Acne Associated with Janus Kinase Inhibitors

Authors: Christopher G. Bunick, MD, PhD; Naiem T. Issa, MD, PhD; Julie C. Harper, MD; Hilary Baldwin, MD; Joshua A. Zeichner, MD; Leon H. Kircik MD

Cutaneous acneiform...

CME Satellite Symposium: Keep the Conversation Going: Optimizing Psoriatic Disease Outcomes With GLP-1 Receptor Agonists

Erin E. Boh, MD, PhD, began by reviewing the immunologic pathways of psoriasis and highlighted how weight and comorbidities can contribute to treatment resistance and persistent inflammation in...

Skin Cancer: What’s New in 2025 That You Need to Know

Darrell S. Rigel, MD, MS, delivered a comprehensive overview of the most significant skin cancer updates for 2025, covering advances in epidemiology, diagnostics, and treatment.

He began with...

What’s Itching You Today? Contact Derm? Atopic Derm? What Else?

Shawn G. Kwatra, MD, presented a compelling session on the evaluation and management of chronic itch, underscoring its profound impact on patient quality of life. Chronic pruritus, he...

CME Satellite Symposium: Illuminate the Role of IL-13 Inhibitors for the Management of Atopic Dermatitis

Alexandra Golant, MD, Mona Shahriari, MD, and G. Michael Lewitt, MD, presented a session focused on the evolving role of interleukin-13 (IL-13) inhibition in atopic dermatitis, sharing new...

Impact of Simultaneous Itch Relief and Substantial Skin Clearance with Lebrikizumab in Patients with Atopic Dermatitis: Post-Hoc Analysis from ADvocate1/2

Authors: Raj Chovatiya, Khai Jing Ng, H. Chih-Ho Hong, Yousef Binamer, Evangeline Pierce, Meihua Qiao, Eric Wolf, Melinda Gooderham

The ADvocate1 and ADvocate2 trials were pivotal phase 3...

Baricitinib in the Treatment of Frontal Fibrosing Alopecia: Mid Trial Update

Authors: Alia Abbas, MD; Tyler Downing, MD; Chiemelum Amechi, MD; Tiffany Mayo, MD, FAAD; Boni Elewski, MD, FAAD

Frontal fibrosing alopecia (FFA) is a chronic inflammatory scarring alopecia...

The Changing Landscape of Topical Therapies

Linda Stein Gold, MD, MS, Cheri Frey, MD, FAAD, Peter Lio, MD, FAAD, and Bruce Strober, MD, PhD, led an expert discussion highlighting cutting-edge advances in topical dermatologic...

CME Satellite Symposium: Tips and Tricks to Advancing Chronic Spontaneous Urticaria Care

Marc Serota, MD, and Michelle Tarbox, MD, led an in-depth session on the evolving management of chronic spontaneous urticaria (CSU), emphasizing diagnostic precision, disease activity assessment, and the...

Seminar-in-Depth: On the Verge of Better Management for Chronic Hand Eczema

Benjamin Ehst, MD, PhD, and Alexandra Golant, MD, presented an insightful session focused on the complex diagnosis and evolving treatment landscape of chronic hand eczema (CHE), a condition...

Pediatric Dermatology – Who Has Better Pearls?

Lawrence F. Eichenfield, MD, started the session, delivering a highly informative lecture centered on practical pediatric dermatology pearls that enhance both diagnostic accuracy and patient care. Dr Eichenfield...

Safety of Delgocitinib Cream in Adult Patients With Chronic Hand Eczema: Pooled Analysis of Five Phase 2b and Phase 3 Trials

Authors: Robert Bissonnette, Tove Agner, Ana Maria Giménez-Arnau, Jonathan I. Silverberg, Cherry Lou Balita-Crisostomo, Simone Riis Laursen, Douglas Maslin, Ariane Pelletier, Sibylle Schliemann

Delgocitinib, a topical pan-JAK inhibitor,...

Long-Term Efficacy and Tolerability of Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel for Acne: Pooled Results From Two 6-Month Studies

Authors: Zoe D. Draelos, MD, Hilary Baldwin, MD, Julie C. Harper, MD, Mahmoud Ghannoum, PhD, Linda Stein Gold, MD, Emil A. Tanghetti, MD, Eric Guenin, PharmD, PhD, MPH,...

15 Tips in 15 Minutes

Mark Lebwohl, MD, opened with updates on ritlecitinib, highlighting sustained scalp and brow regrowth in patients with alopecia areata over 24 to 48 weeks, and described a five-year...

Melasma and Other Hyperpigmentation Disorders

Andrew F. Alexis, MD, MPH, began by reviewing the multifactorial pathophysiology of melasma, which involves ultraviolet (UV) and visible light exposure, hormonal triggers, vascular changes, and inflammatory signaling....

Answers to Hair Questions: Alopecia Areata and Beyond

Natasha Atanaskova-Mesinkovska, MD, PhD, presented an engaging overview of both established and emerging treatments for hair loss. She began with a classic focus on minoxidil, highlighting dosing differences...

Pearls in Managing Inflammatory Skin Diseases

Brett King, MD, PhD, and E. James Song, MD, delivered a comprehensive and practical session on inflammatory skin diseases, focusing on the evolving role of JAK inhibitors (JAKis)...

Icotrokinra Demonstrated Superior Responses Compared with Placebo and Deucravacitinib in the Treatment of Moderate-to-Severe Plaque Psoriasis: Results Through Week 24 of the Phase 3 ICONIC-ADVANCE 1&2 Studies

Authors: Linda Stein Gold, April W. Armstrong, Robert Bissonnette, Nina Magnolo, Ronald B. Vender, Michael Sebastian, Maria Laura Galimberti, Athanasios Tsianakas, Marcelo Arnone, Paul Wallace, Margrit Simon, Josep...

SPECTREM: Guselkumab Impact on Nail Psoriasis and Psoriatic Arthritis Through Week 48 in Participants With Low BSA, Moderate Psoriasis With High-Impact Site Involvement

Authors: Alice B. Gottlieb, Joseph F. Merola, Kim A. Papp, Marni Wiseman, Wei Jing Loo, Joe K. Tung, Theodore Alkousakis, Daphne Chan, Soumya D. Chakravarty, Jenny Jeyarajah, Richard...